Lorbrexen 100 mg (Lorlatinib), generic Lorbrena is a prescription medicine used to treat metastatic non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. It is used in patients who have already received alectinib, ceritinib, or both crizotinib and at least 1 other medicine to treat NSCLC that is caused by the ALK gene. Lorbrexen is manufactured by Everest Pharma Ltd. in Bangladesh.
Lorbrexen 100 Mg (Lorlatinib) Price & Offer
- Post author:admin
- Post published:April 8, 2016
- Post category:Antirheumatic / Breast Cancer
- Post comments:0 Comments